1. Home
  2. INBS vs SYNX Comparison

INBS vs SYNX Comparison

Compare INBS & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.65

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

N/A

Current Price

$1.05

Market Cap

6.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
SYNX
Founded
2016
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.8M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
INBS
SYNX
Price
$1.65
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 118.6K
41.8K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,980,484.00
N/A
Revenue This Year
$778.48
$32.35
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.73
52 Week High
$24.90
$1.95

Technical Indicators

Market Signals
Indicator
INBS
SYNX
Relative Strength Index (RSI) 31.09 61.76
Support Level $1.52 $1.04
Resistance Level $2.45 $1.09
Average True Range (ATR) 0.13 0.07
MACD -0.05 0.03
Stochastic Oscillator 4.62 96.27

Price Performance

Historical Comparison
INBS
SYNX

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sells push-to-talk devices, communication controllers, and communication device cables and connectors. Geographically, it generates the majority of its revenue from Israel.

Share on Social Networks: